SAN-300

· Bausch Health Americas, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SAN-300, covering 2021-06-21 to 2021-06-21. Get the full timeline:

Most recent: Clinical Trial Update: (C2013-0302) Safety and Efficacy of Escalating Doses of SAN-300 in Patients With Rheumatoid Arthritis [Phase 2]